跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT05495360
NCT05495360已完成不适用

Effect of Omega 3 Enriched Oral Nutritional Supplement on Nutritional Status of CRC and NSCLC Patients

Nutricia Research6 个研究点 分布在 3 个国家目标入组 48 人开始时间: 2023年1月17日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48
试验地点
6
主要终点
Change in EPA concentration in the phospholipid fraction of the erythrocyte membrane [% of total fatty acids]
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

A single arm intervention study examining the effect of an omega 3 enriched oral nutritional supplement on nutritional status of CRC and NSCLC patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •Histologically proven CRC or histologically or cytologically proven NSCLC
  • •Eligible and scheduled for at least 2 cycles of 4-week cycles of systemic treatment, 3 cycles of 3-week cycles of systemic treatment or 4 cycles of 2-week cycles of systemic treatment
  • •At risk of malnutrition or malnourished [PG-SGA-SF > 4]
  • •Performance status ECOG 0 or 1
  • •Weight loss grade 0-3 according to Martin et al1
  • •<11% weight loss in the past 6 months
  • •Age ≥ 18 years
  • •Written informed consent

排除标准

  • •Presence of ileostoma or ileal pouch
  • •GI-related or major surgery in 30 days prior to baseline
  • •Severe hypercalcemia, i.e. total calcium level, corrected for albumin ≥ 14.0 mg/dL (3.5 mmol/L)
  • •Use of ONS, enteral nutrition or parenteral nutrition within 14 days prior to entry into the study
  • •Use of fish oil containing supplements, within 30 days prior to entry into the study or expected to use this during the study
  • •Use of more than 200 iU/day of vitamin D containing supplements within 30 days prior to entry into the study or expected to use this during the study
  • •Life expectancy of < 3 months
  • •Severe renal dysfunction (<29 ml/min/1.73m2 eGRF or albumin:creatinine (ACR) > 30) or hepatic encephalopathy
  • •Allergy to cow's milk protein or fish, known protein sensitivity or suffering galactosemia
  • •Known pregnancy or lactation
  • •Current alcohol or drug abuse in opinion of the investigator
  • •Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
  • •Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study

结局指标

主要结局

Change in EPA concentration in the phospholipid fraction of the erythrocyte membrane [% of total fatty acids]

时间窗: at end of first in-study treatment cycle compared to baseline

次要结局

  • Change in protein intake [g/day] [key secondary outcome)(at end of first in-study treatment cycle compared to baseline)
  • Change in energy intake [kcal/day](at end of first in-study treatment cycle compared to baseline)
  • Change in protein intake [g/kg bw/day] [key secondary outcome)(at end of first in-study treatment cycle compared to baseline)
  • Change in fatty acid profile in the phospholipid fraction of the cell membrane of erythrocytes [% of total fatty acids](at end of first in-study treatment cycle compared to baseline)
  • Change in energy intake [kcal/kg bw/day](at end of first in-study treatment cycle compared to baseline)
  • Provided vitamin D supplementation [µg/day] by the test product(Throughout total intervention period - about 2 months)

研究者

发起方
Nutricia Research
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

已完成
不适用
Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older AdultsChronic Venous Leg Ulcers
NCT03576989Ohio State University96
已完成
Unknown
Effect of omega-3 supplementation on myelination, inflammation, and chronic fatigue in patients with multiple sclerosisMultiple Sclerosis.Multiple sclerosis (of):NOS brain stem cord disseminated generalized
IRCT20240604062003N1Abadan University of Medical Sciences30
已完成
2 期
Evaluation of the effect of omega-3 supplementation on lipid profile, insulin resistance, inflammatory parameters and SIRT1 in obese children and adolescents, a randmized placebo controlled clinical trial
IRCT201612014585N10Iran University of Medical Sciences60
招募中
3 期
The effects of omega-3 supplementation in patients with Hashimoto's diseaseHashimoto's disease.Autoimmune thyroiditisE06.3
IRCT20150815023617N7Shahid Beheshti University of Medical Sciences60
招募中
3 期
Assessment the Effect of omega 3 supplementation on Improving Metabolic Syndrome indices
IRCT20190819044563N1Oroumia University of Medical Sciences90
Effect of Omega 3 Enriched Oral Nutritional... | 临床试验